Health Benefits of Traditional culinary and Medicinal Mediterranean Plants

Complementary and Alternative Therapies and the Aging Population

Volumn , Issue , 2009, Pages 541-562

  Degner, Stephanie C ^a   Papoutsis, Andreas J ^a   Romagnolo, Donato F ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882867197     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374228-5.00026-3     Document Type: Chapter

References (133)

1. Knoops K.T., de Groot L.C., Kromhout D., Perrin A.E., Moreiras-Varela O., Menotti A., van Staveren W.A. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: The HALE project. JAMA 2004, 292(12):1433-1439.
2. Trichopoulou A., Costacou T., Bamia C., Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003, 348(26):2599-2608.
3. Fitó M., Guxens M., Corella D., Sáez G., Estruch R., de la Torre R., Francés F., Cabezas C., López-Sabater Mdel C., Marrugat J., García-Arellano A., Arós F., Ruiz-Gutierrez V., Ros E., Salas-Salvadó J., Fiol M., Solá R., Covas M.I. Effect of a traditional Mediterranean diet on lipoprotein oxidation: A randomized controlled trial. Arch Intern Med 2007, 167(11):1195-1203. for the PREDIMED Study Investigators.
4. Ninfali P., Mea G., Giorgini S., Rocchi M., Bacchiocca M. Antioxidant capacity of vegetables, spices and dressings relevant to nutrition. Br J Nutr 2005, 93(2):257-266.
5. Hemphill I., Cobiac L. Health benefits of herbs and spices: The past, the present, the future. The historical and cultural use of herbs and spices. Med J Aust 2006, 185(4 Suppl):S5.
6. Trichopoulou A., Critselis E. Mediterranean diet and longevity. Eur J Cancer Prev, 2004, 13(5):453-456.
7. Tapsell L.C. Health benefits of herbs and spices: The past, the present, the future. Herbs and spices as functional foods. Med J Aust 2006, 185(4 Suppl):S6.
8. Patch C.S., Sullivan D.R. Health benefits of herbs and spices: Health benefits of herbs and spices: The past, the present, the future. Cardiovascular disease. Med J Aust 2006, 185(4 Suppl):S7.
9. Bozin B., Mimica-Dukic N., Samojlik I., Jovin E. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric Food Chem 2007, 55(19):7879-7885.
10. Cheung S., Tai J. Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol Rep 2007, 17(6):1525-1531.
11. Hsieh, C. L., Peng, C. H., Chyau, C. C., Lin, Y. C., Wang, H. E. & Peng, R. Y. Low-density lipoprotein, collagen, and thrombin models reveal that Rosemarinus officinalis L. exhibits potent antiglycative effects. J Agric Food Chem. 2007;55(8), 2884-2891 (Epub 2007 Mar 27. Erratum in: J Agric Food Chem. 2007;55(11), 4624).
12. Moss M., Cook J., Wesnes K., Duckett P. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. Int J Neurosci 2003, 113(1):15-38.
13. Angioni A., Barra A., Cereti E., Barile D., Coïsson J.D., Arlorio M., Dessi S., Coroneo V., Cabras P. Chemical composition, plant genetic differences, antimicrobial and antifungal activity investigation of the essential oil of Rosmarinus officinalis L. J Agric Food Chem 2004, 52(11):3530-3535.
14. del Baño M.J., Lorente J., Castillo J., Benavente-García O., del Río J.A., Ortuño A., Quirin K.W., Gerard D. Phenolic diterpenes, flavones, and rosmarinic acid distribution during the development of leaves, flowers, stems, and roots of Rosmarinus officinalis. Antioxidant activity. J Agric Food Chem 2003, 51(15):4247-4253.
15. Frankel E., Huang S., Aescherbach R., Prior E. Antioxidant activity of a rosemary extract and its constituents, carnosic acid, carnosol, and rosmarinic acid, in bilk oil and oil-in-water emulsion. J Agric Food Chem 1996, 44(1):131-135.
16. 2 or visible light-excited Methylene Blue. Cancer Lett 2002 Mar 28, 177(2):145-153.
17. Offord E.A., Macé K., Ruffieux C., Malnoë A., Pfeifer A.M. Rosemary components inhibit benzo[a]pyrene-induced genotoxicity in human bronchial cells. Carcinogenesis 1995, 16(9):2057-2062.
18. Singletary K.W., Rokusek J.T. Tissue-specific enhancement of xenobiotic detoxification enzymes in mice by dietary rosemary extract. Plant Foods Hum Nutr 1997, 50(1):47-53.
19. Soyal D., Jindal A., Singh I., Goyal P.K. Modulation of radiation-induced biochemical alterations in mice by rosemary (Rosemarinus officinalis) extract. Phytomedicine 2007, 14(10):701-705.
20. Sotelo-Félix J.I., Martinez-Fong D., Muriel P., Santillán R.L., Castillo D., Yahuaca P. Evaluation of the effectiveness of Rosmarinus officinalis (Lamiaceae) in the alleviation of carbon tetrachloride-induced acute hepatotoxicity in the rat. J Ethnopharmacol 2002, 81(2):145-154.
21. Amagase H., Sakamoto K., Segal E.R., Milner J.A. Dietary rosemary suppresses 7,12-dimethylbenz(a)anthracene binding to rat mammary cell DNA. J Nutr 1996, 126(5):1475-1480.
22. Singletary K.W., Nelshoppen J.M. Inhibition of 7,12 dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and of in vivo formation of mammary DMBA-DNA adducts by rosemary extract. Cancer Lett 1991, 60(2):169-175.
23. Alexandrov K., Rojas M., Rolando C. DNA damage by benzo(a)pyrene in human cells is increased by cigarette smoke and decreased by a filter containing rosemary extract, which lowers free radicals. Cancer Res 2006, 66(24):11938-11945.
24. Sancheti G., Goyal P.K. Effect of Rosmarinus officinalis in modulating 7,12-dimethylbenz(a)anthracene induced skin tumorigenesis in mice. Phytother Res 2006, 20(11):981-986.
25. Nolkemper S., Reichling J., Stintzing F.C., Carle R., Schnitzler P. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro. Planta Med 2006, 72(15):1378-1382.
26. Mahady G.B., Pendland S.L., Stoia A., Hamill F.A., Fabricant D., Dietz B.M., Chadwick L.R. In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res 2005, 19(11):988-991.
27. Sharabani H., Izumchenko E., Wang Q., Kreinin R., Steiner M., Barvish Z., Kafka M., Sharoni Y., Levy J., Uskokovic M., Studzinski G.P., Danilenko M. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int J Cancer 2006, 118(12):3012-3021.
28. Yamamoto J., Yamada K., Naemura A., Yamashita T., Arai R. Testing various herbs for antithrombotic effect. Nutrition 2005, 21(5):580-587.
29. Scarpati M.L., Oriente G. Isolamento e costituzione dell'acido rosmarinico (dal rosmarinus off.). Ric Sci 1958, 28:2329-2333.
30. Petersen M., Simmonds M.S. Rosmarinic acid. Phytochemistry 2003, 62(2):121-125.
31. Al-Sereitia M.R., Abu-Amerb K.M., Sena P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exper Biol 1999, 37:124-131.
32. Baba S., Osakabe N., Natsume M., Yasuda A., Muto Y., Hiyoshi K., Takano H., Yoshikawa T., Terao J. Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans. Eur J Nutr 2005, 44(1):1-9.
33. Nakazawa T., Ohsawa K. Metabolites of orally administered Perilla frutescens extract in rats and humans. Biol Pharm Bull 2000, 23(1):122-127.
34. Osakabe N., Yasuda A., Natsume M., Yoshikawa T. Rosmarinic acid inhibits epidermal inflammatory responses: Anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis 2004, 25(4):549-557.
35. Osakabe N., Takano H., Sanbongi C., Yasuda A., Yanagisawa R., Inoue K., Yoshikawa T. Anti-inflammatory and anti-allergic effect of rosmarinic acid (RA); inhibition of seasonal allergic rhinoconjunctivitis (SAR) and its mechanism. Biofactors 2004, 21(1-4):127-131.
36. Atsumi T., Tonosaki K. Smelling lavender and rosemary increases free radical scavenging activity and decreases cortisol level in saliva. Psychiatry Res 2007, 150(1):89-96.
37. Huang S.S., Zheng R.L. Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett 2006, 239(2):271-280.
38. Lee J., Kim Y.S., Park D. Rosmarinic acid induces melanogenesis through protein kinase A activation signaling. Biochem Pharmacol 2007, 74(7):960-968.
39. Kim D.S., Kim H.R., Woo E.R., Hong S.T., Chae H.J., Chae S.W. Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase. Biochem Pharmacol 2005, 70(7):1066-1078.
40. 2+-dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-gamma 1 and Itk activity. Blood 2003, 101(9):3534-3542.
41. Chang C.H., Chyau C.C., Hsieh C.L., Wu Y.Y., Ker Y.B., Tsen H.Y., Peng R.Y. Relevance of phenolic diterpene constituents to antioxidant activity of supercritical CO(2) extract from the leaves of rosemary. Nat Prod Res 2008, 22(1):76-90.
42. Pérez-Fons L., Aranda F.J., Guillén J., Villalaín J., Micol V. Rosemary (Rosmarinus officinalis) diterpenes affect lipid polymorphism and fluidity in phospholipid membranes. Arch Biochem Biophys 2006, 453(2):224-236.
43. Munné-Bosch S., Alegre L. Subcellular compartmentation of the diterpene carnosic acid and its derivatives in the leaves of rosemary. Plant Physiol 2001, 125(2):1094-1102.
44. Singletary K., MacDonald C., Wallig M. Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett 1996, 104(1):43-48.
45. Huang M.T., Ho C.T., Wang Z.Y., Ferraro T., Lou Y.R., Stauber K., Ma W., Georgiadis C., Laskin J.D., Conney A.H. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 1994, 54(3):701-708.
46. Huang S.C., Ho C.T., Lin-Shiau S.Y., Lin J.K. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B an c-Jun. Biochem Pharmacol 2005, 69(2):221-232.
47. Visanji J.M., Thompson D.G., Padfield P.J. Induction of G2/M phase cell cycle arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B1 levels. Cancer Lett 2006, 237(1):130-136.
48. Costa S., Utan A., Speroni E., Cervellati R., Piva G., Prandini A., Guerra M.C. Carnosic acid from rosemary extracts: A potential chemoprotective agent against aflatoxin B1. An in vitro study. J Appl Toxicol 2007, 27(2):152-159.
49. Lee J.J., Jin Y.R., Lee J.H., Yu J.Y., Han X.H., Oh K.W., Hong J.T., Kim T.J., Yun Y.P. Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis. Planta Med 2007, 73(2):121-127.
50. Rau O., Wurglics M., Paulke A., Zitzkowski J., Meindl N., Bock A., Dingermann T., Abdel-Tawab M., Schubert-Zsilavecz M. Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Med 2006, 72(10):881-887.
51. González-Mahave I., Lobesa T., Del Pozo M.D., Blasco A., Venturini M. Rosemary contact dermatitis and cross-reactivity with other labiate plants. Contact Dermatitis 2006, 54(4):210-212.
52. Nusier M.K., Bataineh H.N., Daradkah H.M. Adverse effects of rosemary (Rosmarinus officinalis L.) on reproductive function in adult male rats. Exp Biol Med (Maywood) 2007, 232(6):809-813.
53. Debersac P., Heydel J.M., Amiot M.J., Goudonnet H., Artur Y., Suschetet M., Siess M.H. Induction of cytochrome P450 and/or detoxication enzymes by various extracts of rosemary: Description of specific patterns. Food Chem Toxicol 2001, 39(9):907-918.
54. Peng C.H., Su J.D., Chyau C.C., Sung T.Y., Ho S.S., Peng C.C., Peng R.Y. Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects. Biosci Biotechnol Biochem 2007, 71(9):2223-2232.
55. Keokamnerd T., Acton J.C., Han I.Y., Dawson P.L. Effect of commercial rosemary oleoresin preparations on ground chicken thigh meat quality packaged in a high-oxygen atmosphere. Poult Sci 2008, 87(1):170-179.
56. Bentayeb K., Rubio C., Batlle R., Nerín C. Direct determination of carnosic acid in a new active packaging based on natural extract of rosemary. Anal Bioanal Chem 2007, 389(6):1989-1996.
57. Minich D.M., Bland J.S., Katke J., Darland G., Hall A., Lerman R.H., Lamb J., Carroll B., Tripp M. Clinical safety and efficacy of NG440: A novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditions. Can J Physiol Pharmacol 2007, 85(9):872-883.
58. Shin B.C., Lee M.S. Effects of aromatherapy acupressure on hemiplegic shoulder pain and motor power in stroke patients: A pilot study. J Altern Complement Med 2007, 13(2):247-251.
59. Fiore C., Eisenhut M., Ragazzi E., Zanchin G., Armanini D. A history of the therapeutic use of liquorice in Europe. J Ethnopharmacol 2005, 99(3):317-324.
60. Hemphill I. The Spice and Herb Bible 2006, Robert Rose Inc, Toronto, Ontario, Canada. (2nd ed.).
61. Isbrucker R.A., Burdock G.A. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 2006, 46(3):167-192.
62. Whorwood C.B., Sheppard M.C., Stewart P.M. Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology 1993, 132(6):2287-2292.
63. Sigurjónsdóttir H.A., Franzson L., Manhem K., Ragnarsson J., Sigurdsson G., Wallerstedt S. Liquorice-induced rise in blood pressure: A linear dose-response relationship. J Hum Hypertens 2001, 15(8):549-552.
64. de Klerk G.J., Nieuwenhuis M.G., Beutler J.J. Hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum. BMJ 1997, 314(7082):731-732.
65. Blumenthal M. The Complete German Commission E Monographs - Therapeutic Guide to Herbal Medicines 2000, Integrative Medicine Communications, Newton, MA.
66. Chevallier A. The Encyclopedia of Medicinal Plants 1996, DK Publishing Inc, New York, NY.
67. Saeedi M., Morteza-Semnani K., Ghoreishi M.R. The treatment of atopic dermatitis with licorice gel. J Dermatol Treat 2003, 14(3):153-157.
68. Chin Y.W., Jung H.A., Liu Y., Su B.N., Castoro J.A., Keller W.J., Pereira M.A., Kinghorn A.D. Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra). J Agric Food Chem 2007, 55(12):4691-4697.
69. Baumann L.S. Less-known botanical cosmeceuticals. Dermatol Ther 2007, 20(5):330-342.
70. O'Hara M., Kiefer D., Farrell K., Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998, 7(6):523-536.
71. Mann C., Staba E.J. The chemistry, pharmacology, and commercial formulations of Chamomile. Herbs, Spices, and Medicinal Plants: Recent Advances in Botany, Horticulture, and Pharmacology 1986, Vol. 1:235-280. Oryx Press, Phoenix. L.E. Craker, J.E. Simon (Eds.).
72. McKay D.L., Blumberg J.B. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res. 2006, 20(7):519-530.
73. Kotov A.G., Khvorost P.P., Komissarenko N.F. Coumarins of Matricaria recutita. Chem Nat Compd 1991, 27:753.
74. Patel D., Shukla S., Gupta S. Apigenin and cancer chemoprevention: Progress, potential and promise (review). Int J Oncol 2007, 30(1):233-245.
75. Dragland S., Senoo H., Wake K., Holte K., Blomhoff R. Several culinary and medicinal herbs are important sources of dietary antioxidants. J Nutr 2003, 133(5):1286-1290.
76. Nakamura H., Moriya K., Oda S., Yano E., Kakuta H. Changes in the parameters of autonomic nervous system and emotion spectrum calculated from encephalogram after drinking chamomile tea. [Japanese]. Aroma Res 2002, 3:251-255.
77. Gould L., Reddy C.V., Gomprecht R.F. Cardiac effects of chamomile tea. J Clin Pharmacol 1973, 13(11):475-479.
78. de la Motte S., Böse-O'Reilly S., Heinisch M., Harrison F. Double-blind comparison of an apple pectin-chamomile extract preparation with placebo in children with diarrhea [German]. Arzneimittelforschung 1997, 47(11):1247-1249.
79. Maiche A.G., Gröhn P., Mäki-Hokkonen H. Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 1991, 30(3):395-396.
80. Glowania H.J., Raulin C., Swoboda M. Effect of chamomile on wound healing: A clinical double-blind study. Z Hautkr 1987, 62(17):1262. 1267-1271.
81. Hartman D., Coetzee J.C. Two US practitioners' experience of using essential oils for wound care. J Wound Care 2002, 11:317-320.
82. Kyokong O., Charuluxananan S., Muangmingsuk V., Rodanant O., Subornsug K., Punyasang W. Efficacy of chamomile-extract spray for prevention of post-operative sore throat. J Med Assoc Thai 2002, 85(Suppl 1):S180-S185.
83. Subiza J., Subiza J.L., Hinojosa M., Garcia R., Jerez M., Valdivieso R., Subiza E. Anaphylactic reaction after the ingestion of chamomile tea: A study of cross-reactivity with other composite pollens. J Allergy Clin Immunol 1989, 84(3):353-358.
84. Reider N., Sepp N., Fritsch P., Weinlich G., Jensen-Jarolim E. Anaphylaxis to camomile: Clinical features and allergen cross-reactivity. Clin Exp Allergy 2000, 30(10):1436-1443.
85. Paulsen E. Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatitis 2002, 47(4):189-198.
86. Nowack R., Nowak B. Herbal teas interfere with cyclosporin levels in renal transplant patients. Nephrol Dial Transplant 2005, 20(11):2554-2556.
87. Heck A.M., DeWitt B.A., Lukes A.L. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000, 57:1221-1227.
88. Waterman E., Lockwood B. Active components and clinical applications of olive oil. Altern Med Rev 2007, 12(4):331-342.
89. Tuck K.L., Hayball P.J. Major phenolic compounds in olive oil: Metabolism and health effects. J Nutr Biochem 2002, 13(11):636-644.
90. Trichopoulou A., Dilis V. Olive oil and longevity. Mol Nutr Food Res 2007, 51(10):1275-1278.
91. Alarcón de la Lastra C., Barranco M.D., Motilva V., Herrerías J.M. Mediterranean diet and health: Biological importance of olive oil. Curr Pharm Des 2001, 7(10):933-950.
92. Velasco J., Dobarganes C. Oxidative stability of virgin olive oil. Eur J Lipid Sci Technol 2002, 104:661-676.
93. Carrasco-Pancorbo A., Cerretani L., Bendini A., Segura-Carretero A., Lercker G., Fernández-Gutiérrez A. Evaluation of the influence of thermal oxidation on the phenolic composition and on the antioxidant activity of extra-virgin olive oils. J Agric Food Chem 2007, 55(12):4771-4780.
94. Visioli F., Poli A., Gall C. Antioxidant and other biological activities of phenols from olives and olive oil. Med Res Rev 2002, 22(1):65-75.
95. Gutiérrez-Rosales F., Ríos J.J., Gómez-Rey M.L. Main polyphenols in the bitter taste of virgin olive oil. Structural confirmation by on-line high-performance liquid chromatography electrospray ionization mass spectrometry. J Agric Food Chem 2003, 51(20):6021-6025.
96. Visioli F., Bellomo G., Montedoro G., Galli C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis 1995, 117(1):25-32.
97. Bartsch H., Nair J., Owen R.W. Exocyclic DNA adducts as oxidative stress markers in colon carcinogenesis: Potential role of lipid peroxidation, dietary fat and antioxidants. Biol Chem 2002, 383(6):915-921.
98. Escrich E., Moral R., Grau L., Costa I., Solanas M. Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol Nutr Food Res Oct 2007, 51(10):1279-1292.
99. Keys A., Menotti A., Karvonen M.J., Aravanis C., Blackburn H., Buzina R., Djordjevic B.S., Dontas A.S., Fidanza F., Keys M.H., et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986, 124(6):903-915.
100. Covas M.I. Olive oil and the cardiovascular system. Pharmacol Res 2007, 55(3):175-186.
101. Psaltopoulou, T., Naska, A., Orfanos, P., Trichopoulos, D., Mountokalakis, T., Trichopoulou, A., Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2004 Oct; 80(4): 1012-8. Erratum in: Am J Clin Nutr 2005, 81(5), 1181.
102. Trevisan, M., Krogh, V., Freudenheim, J., Blake, A., Muti, P., Panico, S., Farinaro, E., Mancini, M., Menotti, A. & Ricci G. Consumption of olive oil, butter, and vegetable oils and coronary heart disease risk factors. The Research Group ATS-RF2 of the Italian National Research Council. JAMA. 1990; 263(5): 688-692. Erratum in: JAMA 1990, 263(13), 1768.
103. Alonso A., Martínez-González M.A. Olive oil consumption and reduced incidence of hypertension: The SUN study. Lipids 2004, 39(12):1233-1238.
104. Alonso A., Ruiz-Gutierrez V., Martínez-González M.A. Monounsaturated fatty acids, olive oil and blood pressure: Epidemiological, clinical and experimental evidence. Public Health Nutr 2006, 9(2):251-257.
105. Ferrara L.A., Raimondi A.S., d'Episcopo L., Guida L., Dello Russo A., Marotta T. Olive oil and reduced need for antihypertensive medications. Arch Intern Med 2000, 160(6):837-842.
106. Lopez-Miranda J., Delgado-Lista J., Perez-Martinez P., Jimenez-Gómez Y., Fuentes F., Ruano J., Marin C. Olive oil and the haemostatic system. Mol Nutr Food Res 2007, 51(10):1249-1259.
107. Ruano J., López-Miranda J., de la Torre R., Delgado-Lista J., Fernández J., Caballero J., Covas M.I., Jiménez Y., Pérez-Martínez P., Marín C., Fuentes F., Pérez-Jiménez F. Intake of phenol-rich virgin olive oil improves the postprandial prothrombotic profile in hypercholesterolemic patients. Am J Clin Nutr 2007, 86(2):341-346.
108. Oubiña P., Sánchez-Muniz F.J., Ródenas S., Cuesta C. Eicosanoid production, thrombogenic ratio, and serum and LDL peroxides in normo- and hypercholesterolaemic post-menopausal women consuming two oleic acid-rich diets with different content of minor components. Br J Nutr 2001, 85(1):41-47.
109. Visioli F., Caruso D., Grande S., Bosisio R., Villa M., Galli G., Sirtori C., Galli C.Virgin. Olive Oil Study (VOLOS): Vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. Eur J Nutr 2005, 44(2):121-127.
110. Bogani P., Galli C., Villa M., Visioli F. Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis 2007, 190(1):181-186.
111. Hargrove R.L., Etherton T.D., Pearson T.A., Harrison E.H., Kris-Etherton P.M. Low fat and high monounsaturated fat diets decrease human low density lipoprotein oxidative susceptibility in vitro. J Nutr 2001, 131(6):1758-1763.
112. Wiseman S.A., Mathot J.N., de Fouw N.J., Tijburg L.B. Dietary non-tocopherol antioxidants present in extra virgin olive oil increase the resistance of low density lipoproteins to oxidation in rabbits. Atherosclerosis 1996, 120(1-2):15-23.
113. Machowetz A., Poulsen H.E., Gruendel S., Weimann A., Fitó M., Marrugat J., de la Torre R., Salonen J.T., Nyyssönen K., Mursu J., Nascetti S., Gaddi A., Kiesewetter H., Bäumler H., Selmi H., Kaikkonen J., Zunft H.J., Covas M.I., Koebnick C. Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans. FASEB J 2007, 21(1):45-52.
114. Hodge A.M., English D.R., McCredie M.R., Severi G., Boyle P., Hopper J.L., Giles G.G. Foods, nutrients and prostate cancer. Cancer Causes Control 2004, 15:11-20.
115. Trichopoulou A., Katsouyanni K., Stuver S., Tzala L., Gnardellis C., Rimm E., Trichopoulos D. Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J Natl Cancer Inst 1995, 87:110-116.
116. Braga C., La Vecchia C., Franceschi S., Negri E., Parpinel M., Recarli A., Giocosa A., Trichopoulos D. Olive oil, other seasoning fats, and the risk of colorectal carcinoma. Cancer 1998, 82:448-453.
117. Franceschi S., Favero A., Conti E., Talamini R., Volpe R., Negri E., Barzan L., La Vecchia C. Food groups, oils and butter, and cancer of the oral cavity and pharynx. Br J Cancer 1999, 80:614-620.
118. Escrich E., Moral R., Grau L., Costa I., Solanas M. Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol Nutr Food Res. 2007, 51(10):1279-1292.
119. Llor X., Pons E., Roca A., Alvarez M., Mañé J., Fernández-Bañares F., Gassull M.A. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes. Clin Nutr 2003, 22(1):71-79.
120. Brunelleschi S., Bardelli C., Amoruso A., Gunella G., Ieri F., Romani A., Malorni W., Franconi F. Minor polar compounds extra-virgin olive oil extract (MPC-OOE) inhibits NF-kappaB translocation in human monocyte/macrophages. Pharmacol Res 2007, 56(6):542-549.
121. Menendez J.A., Vazquez-Martin A., Colomer R., Brunet J., Carrasco-Pancorbo A., Garcia-Villalba R., Fernandez-Gutierrez A., Segura-Carretero A. Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells. BMC Cancer 2007, 7:80.
122. Hashim Y.Z., Rowland I.R., McGlynn H., Servili M., Selvaggini R., Taticchi A., Esposto S., Montedoro G., Kaisalo L., Wähälä K., Gill C.I. Inhibitory effects of olive oil phenolics on invasion in human colon adenocarcinoma cells in vitro. Int J Cancer 2008, 122(3):495-500.
123. Fabiani R., Rosignoli P., De Bartolomeo A., Fuccelli R., Morozzi G. Inhibition of cell cycle progression by hydroxytyrosol is associated with upregulation of cyclin-dependent protein kinase inhibitors p21(WAF1/Cip1) and p27(Kip1) and with induction of differentiation in HL60 cells. J Nutr 2008, 138(1):42-48.
124. Fini L., Hotchkiss E., Fogliano V., Graziani G., Romano M., De Vol E.B., Qin H., Selgrad M., Boland C.R., Ricciardiello L. Chemopreventive properties of pinoresinol-rich olive oil involve a selective activation of the ATM-p53 cascade in colon cancer cell lines. Carcinogenesis 2007, [Epub ahead of print].
125. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: A meta-analysis. Am J Clin Nutr 1998, 67(3 Suppl):577S-582S.
126. Paniagua J.A., de la Sacristana A.G., Sánchez E., Romero I., Vidal-Puig A., Berral F.J., Escribano A., Moyano M.J., Peréz-Martinez P., López-Miranda J., Pérez-Jiménez F. A MUFA-rich diet improves postprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr 2007, 26(5):434-444.
127. Perona J.S., Vögler O., Sánchez-Domínguez J.M., Montero E., Escribá P.V., Ruiz-Gutierrez V. Consumption of virgin olive oil influences membrane lipid composition and regulates intracellular signaling in elderly adults with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci 2007, 62(3):256-263.
128. Medina E., de Castro A., Romero C., Brenes M. Comparison of the concentration of phenolic compounds in olive oils and other plant oils: Correlation with antimicrobial activity. J Agric Food Chem 2006, 54:4954-4961.
129. Bisignano G., Tomaino A., Lo Cascio R., Crisafi G., Uccella N., Saija A. On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol. J Pharm Pharmacol 1999, 51(8):971-974.
130. Romero C., Medina E., Vargas J., Brenes M., De Castro A. In vitro activity of olive oil polyphenols against Helicobacter pylori. J Agric Food Chem 2007, 55(3):680-686.
131. Budiyanto A., Ahmed N.U., Wu A., Bito T., Nikaido O., Osawa T., Ueda M., Ichihashi M. Protective effect of topically applied olive oil against photocarcinogenesis following UVB exposure of mice. Carcinogenesis 2000, 21(11):2085-2090.
132. Al-Waili N.S. An alternative treatment for pityriasis versicolor, tinea cruris, tinea corporis and tinea faciei with topical application of honey, olive oil and beeswax mixture: An open pilot study. Complement Ther Med 2004, 12(1):45-47.
133. Pérez-Jiménez F., Ruano J., Perez-Martinez P., Lopez-Segura F., Lopez-Miranda J. The influence of olive oil on human health: Not a question of fat alone. Mol Nutr Food Res 2007, 20:1199-1208.